Drug Trial Radar · NCT00761215
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Last checked: Nov 20, 2026Latest source record: Nov 25, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
192
Actual
Start
Sep 17, 2008
Primary completion
Feb 24, 2009
Study completion Feb 24, 2009
Sponsor
- Lead sponsor
- Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Industry
- Sponsor type
- Industry
- First posted
- Sep 29, 2008
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to determine the oral dosage of TR-701 to be used in Phase III studies in patients with complicated skin and skin structure infections.
Conditions
- Skin Diseases, Infectious
- Skin Diseases, Bacterial
Interventions
TR-701 200 mgDrug
oral TR-701 200 mg for 5 to 7 days
TR-701 300 mgDrug
oral TR-701 300 mg for 5 to 7 days
TR-701 400 mgDrug
TR-701 400 mg for 5 to 7 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical Response Rate at Test of Cure in the Clinically Evaluable Analysis SetTime frame: 7 to 14 days after the last dose of study drug
- Clinical Response Rate at Test of Cure in the Clinical Modified Intent to Treat Analysis SetTime frame: 7-14 days after last dose of study drug
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Trius Study Site #011
Dothan, Alabama
Trius Study site #001
Chula Vista, California
Trius Study Site #009
Long Beach, California
Trius Study site #002
Oceanside, California
Trius Study site #010
Pasadena, California
Trius Study site 007
San Francisco, California
Trius Study site 003
San Jose, California
Trius Study site 004
Columbus, Georgia
Trius Study site #006
Ludowici, Georgia
Trius Study site #005
Savannah, Georgia
Trius Study site #012
Springfield, Illinois
Trius study sie #008
Detroit, Michigan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.